查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1777647

全球尿道感染检测市场

Urinary Tract Infection Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 300 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球尿道感染检测市场规模将达 7.237 亿美元

全球尿道感染检测市场规模预计在2024年为6.125亿美元，预计到2030年将达到7.237亿美元，在2024-2030年的分析期内，复合年增长率为2.8%。尿道炎是本报告分析的细分市场之一，预计其复合年增长率为2.1%，到分析期结束时规模将达到3.9亿美元。膀胱炎细分市场在分析期间内的复合年增长率预计为3.9%。

美国市场规模估计为 1.669 亿美元，中国市场预计复合年增长率为 5.2%

预计到2024年，美国尿道感染检测市场规模将达1.669亿美元。作为世界第二大经济体，中国市场规模预计将在2030年达到1.396亿美元，2024年至2030年的复合年增长率为5.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为1.1%和2.1%。在欧洲，预计德国的复合年增长率为1.6%。

全球尿道感染（UTI）检测市场－主要趋势与驱动因素摘要

全球尿道感染负担日益加重，导致诊断需求激增

尿道感染(UTI) 是全球最常见的细菌感染疾病之一，每年影响数亿人，导致诊断检测需求显着增加。各年龄层尿道结石发生率不断上升，尤其是在女性、老年人以及糖尿病、肾臟病或免疫力缺乏人群中，这推动了对快速、准确检测解决方案的持续需求。随着早期诊断和抗生素管理意识的不断增强，医疗保健系统正在增加对照护现场的投资，以减轻医院负担并最大限度地减少抗生素的过度处方。尿道结石復发和併发症通常与导尿管使用和尿路结构性异常有关，这导致住院和门诊诊断程序数量增加。此外，全球范围内，尤其是在长期照护机构中，医院相关感染疾病(HAI) 的增多，推动了对可靠尿道结石筛检通讯协定的需求。随着临床医生努力区分无症状性菌尿和真正的感染疾病，需求正转向更特异性、更灵敏的检测，以准确指导治疗决策。这种不断发展的临床情况正在鼓励诊断实验室、初级保健提供者和紧急护理中心扩大其尿道结石检测能力，从而推动全球尿道结石检测市场的成长。

技术进步和即时诊断如何改变尿道结石检测？

技术创新，加上对速度、准确性和可及性的日益重视，正在显着改变尿道感染感染检测的模式。传统的培养为基础的方法虽然高度可靠，但需要24-48小时才能获得结果，并且逐渐被快速诊断方法补充或取代。现代尿液试纸检测和尿液检查套件可以快速检测亚硝酸盐、白血球酯酶和其他重要的感染指标，使其成为急诊和基层医疗机构的宝贵工具。此外，分子诊断技术，尤其是基于PCR的检测，能够快速识别特定病原体和抗药性基因，显着提高诊断准确性并支持合理的抗生素处方。即时诊断（POC）平台因其便携性、易用性和即时提供结果的能力，正变得越来越流行，尤其是在农村和资源匮乏的地区。自动化尿液分析仪也被整合到临床实验室中，以简化工作流程、减少人工错误并实现高通量检测。此外，智慧型手机连接设备和人工智慧主导的诊断工具正在成为家庭尿道结石监测的新解决方案，尤其是对于患有感染疾病或性行为感染的患者。这些技术进步不仅可以提高诊断的准确性，还能帮助临床医师转向实证、个人化的治疗策略，最终减轻抗生素抗药性和復发性感染疾病的负担。

医疗保健模式和消费行为的改变是否会扩大尿道结石检测市场？

随着医疗保健系统朝向以患者为中心的分散式照护发展，尿道感染检测越来越多地在非传统环境中进行，包括零售诊所、家用检测场所和远端医疗主导的诊断平台。现今的消费者要求便利性、速度和保密性，尤其是对于尿道结石这样敏感的疾病。这导致家用尿道结石检测套组的激增，这些试剂盒可在柜檯或网上购买，提供隐私和快速的自我筛检。这些套件通常使用比色试纸技术或应用程式连接的感测器，帮助使用者准确解释结果并确定何时就医。远端医疗提供者也将尿道结石检测作为备受追捧的服务，通常根据症状和测试确认开出抗生素，而无需亲自就诊。此外，雇主和大学正在提供尿道结石筛检服务作为其职业健康和保健计划的一部分，进一步将检测扩展到传统临床环境之外。在医疗保健方面，医院、疗养院和復健中心对早期发现和感染控制的重视，正在推动定期筛检和导尿后监测。护理机构的扩张，以及患者在医疗保健中的参与度不断提高，正在推动尿道结石检测市场蓬勃发展且快速多样化，并刺激了新的检测方式和分销模式的开发以满足这一需求。

是什么推动了全球尿道感染检测市场的成长？

尿道感染检测市场的成长受到多种因素的共同驱动，包括临床需求、技术进步、人口趋势和不断发展的医疗保健服务。其中一个关键驱动因素是全球尿道结石的上升，尤其是在持续成长的患者群体中，包括女性、老年人以及患有慢性疾病和留置导尿管的患者。同时，人们越来越意识到未经治疗的尿道结石（例如肾臟感染、败血症和慢性復发）的风险，这促使人们更早、更频繁地进行检测。抗生素抗药性的加速发展也促使人们在开立抗生素处方前进行更准确的诊断，鼓励医疗保健提供者采用快速的病原体特异性检测。分子和数位技术的作用日益增强，再加上价格实惠的即时检测套组和家用检测套组的日益普及，正在扩大诊断范围并减少获取障碍。有利的法律规范、支持性的报销政策以及促进感染疾病监测的公共卫生倡议，正在为检测创新和市场成长创造有利环境。此外，远端医疗、行动诊断和诊断即服务 (DaaS) 平台的兴起，正在扩大尿道结石检测服务涵盖偏远地区和服务欠缺人群的范围。随着这些趋势的不断发展，在临床紧迫性、患者赋能和诊断创新等共同驱动下，尿道感染检测市场有望实现强劲且持续的成长。

部分

类型（尿道炎、膀胱炎、肾盂肾炎）；最终用途（全科医生、泌尿系统、泌尿系统、医院实验室、参考实验室、医院急诊科、急诊护理、其他）

受访公司范例

  • Accelerate Diagnostics, Inc.
  • Acutis Diagnostics
  • Becton, Dickinson and Company（BD）
  • Beckman Coulter
  • bioMerieux
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin
  • F. Hoffmann-La Roche Ltd.
  • GENETWORx
  • Healthy.io
  • Patients Choice Laboratories
  • QIAGEN
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • T2 Biosystems, Inc.
  • TestCard
  • Thermo Fisher Scientific, Inc.
  • Uritest Medical
  • Winx

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP33210

Global Urinary Tract Infection Testing Market to Reach US$723.7 Million by 2030

The global market for Urinary Tract Infection Testing estimated at US$612.5 Million in the year 2024, is expected to reach US$723.7 Million by 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Urethritis, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$390.0 Million by the end of the analysis period. Growth in the Cystitis segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$166.9 Million While China is Forecast to Grow at 5.2% CAGR

The Urinary Tract Infection Testing market in the U.S. is estimated at US$166.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$139.6 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Urinary Tract Infection (UTI) Testing Market - Key Trends & Drivers Summarized

Is the Rising Global Burden of UTIs Fueling a Surge in Diagnostic Demand?

Urinary tract infections (UTIs) are among the most common bacterial infections globally, impacting hundreds of millions of people annually and leading to a substantial increase in diagnostic testing. The growing incidence of UTIs across all age groups-particularly among women, the elderly, and individuals with diabetes, kidney conditions, or immunocompromised states-is driving sustained demand for rapid and accurate testing solutions. As awareness of early diagnosis and antimicrobial stewardship increases, healthcare systems are investing more in point-of-care diagnostics to reduce the burden on hospitals and minimize the overprescription of antibiotics. Recurrent and complicated UTIs, often associated with catheter use or structural abnormalities in the urinary tract, further contribute to the growing volume of diagnostic procedures in both inpatient and outpatient settings. Additionally, the global rise in healthcare-acquired infections (HAIs), particularly in long-term care facilities, is heightening the need for reliable UTI screening protocols. As clinicians aim to differentiate between asymptomatic bacteriuria and true infection, demand is shifting toward more specific and sensitive tests that can accurately guide treatment decisions. This evolving clinical landscape is pushing diagnostic laboratories, primary care providers, and urgent care centers to expand their capabilities in UTI detection, driving growth in the global UTI testing market.

How Are Technological Advancements and POC Diagnostics Transforming UTI Testing?

Technological innovation is dramatically reshaping the urinary tract infection testing landscape, with a growing emphasis on speed, accuracy, and accessibility. Traditional culture-based methods, though highly reliable, require 24-48 hours for results and are gradually being supplemented or replaced by rapid diagnostics. Modern urine dipstick tests and urinalysis kits now offer quicker detection of nitrites, leukocyte esterase, and other key indicators of infection, making them valuable tools in emergency departments and primary care settings. Additionally, molecular diagnostics-particularly PCR-based tests-are enabling the rapid identification of specific pathogens and resistance genes, significantly improving the precision of diagnosis and supporting appropriate antibiotic prescribing. Point-of-care (POC) platforms are becoming increasingly popular due to their portability, user-friendliness, and ability to deliver real-time results, particularly in rural or resource-limited environments. Automated urine analyzers are also being integrated into clinical laboratories to streamline workflows, reduce manual error, and allow for high-throughput testing. Furthermore, smartphone-connected devices and AI-driven diagnostic tools are emerging as novel solutions for home-based UTI monitoring, especially for patients with chronic or recurrent infections. These technological advancements are not only optimizing diagnostic accuracy but also helping clinicians move toward evidence-based, individualized treatment strategies, ultimately reducing the burden of antibiotic resistance and recurrent infections.

Are Shifting Healthcare Models and Consumer Behaviors Expanding the Market for UTI Testing?

As healthcare systems evolve toward decentralized, patient-centered care, urinary tract infection testing is increasingly being conducted in non-traditional settings such as retail clinics, home testing environments, and telehealth-driven diagnostic platforms. Consumers today demand convenience, speed, and confidentiality-especially for sensitive conditions like UTIs. This has led to the proliferation of at-home UTI test kits, which can be purchased over the counter or online, offering privacy and rapid self-screening. These kits often utilize colorimetric strip technologies or app-connected sensors that help users interpret results accurately and decide when to seek medical attention. Telemedicine providers have also embraced UTI testing as a high-demand service, often prescribing antibiotics based on symptoms and test confirmations without the need for an in-person visit. Additionally, employers and universities are offering UTI screening services as part of occupational health and wellness programs, further expanding testing beyond traditional clinical environments. On the institutional side, the emphasis on early detection and infection control in hospitals, nursing homes, and rehabilitation centers is driving routine screening and post-catheterization monitoring. This expansion of care settings-alongside greater patient involvement in health management-is fostering a dynamic and rapidly diversifying market for UTI testing, encouraging the development of new test formats and distribution models to meet this demand.

What Is Driving the Global Growth of the Urinary Tract Infection Testing Market?

The growth in the urinary tract infection testing market is driven by multiple converging factors tied to clinical need, technological progress, demographic trends, and healthcare delivery evolution. A major driver is the global increase in UTI prevalence, particularly among women, the elderly, and individuals with chronic illnesses or indwelling catheters, all of whom represent a consistent and expanding patient base. In parallel, rising awareness around the dangers of untreated UTIs-such as kidney infections, sepsis, and chronic recurrence-is prompting earlier and more frequent testing. The acceleration of antimicrobial resistance is also encouraging more precise diagnosis before antibiotic prescription, pushing healthcare providers to adopt rapid and pathogen-specific tests. The growing role of molecular and digital technologies, combined with the increased availability of affordable point-of-care and home-based test kits, is enhancing diagnostic reach and reducing access barriers. Favorable regulatory frameworks, supportive reimbursement policies, and public health initiatives promoting infectious disease surveillance are creating an enabling environment for testing innovation and market growth. Furthermore, the rise of telehealth, mobile diagnostics, and diagnostic-as-a-service (DaaS) platforms is expanding the availability of UTI testing to remote and underserved populations. As these trends continue to evolve, the urinary tract infection testing market is poised for strong and sustained expansion, driven by the combined imperatives of clinical urgency, patient empowerment, and diagnostic innovation.

SCOPE OF STUDY:

The report analyzes the Urinary Tract Infection Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Urethritis, Cystitis, Pyelonephritis); End-Use (General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories, Hospital Emergency Departments, Urgent Care, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Accelerate Diagnostics, Inc.
  • Acutis Diagnostics
  • Becton, Dickinson and Company (BD)
  • Beckman Coulter
  • bioMerieux
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin
  • F. Hoffmann-La Roche Ltd.
  • GENETWORx
  • Healthy.io
  • Patients Choice Laboratories
  • QIAGEN
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • T2 Biosystems, Inc.
  • TestCard
  • Thermo Fisher Scientific, Inc.
  • Uritest Medical
  • Winx

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Urinary Tract Infection Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising UTI Prevalence Among Aging and At-Risk Populations Spurs Global Testing Demand
    • Growth in Recurrent and Complicated UTI Cases Strengthens Business Case for Rapid and Accurate Diagnostics
    • Increased Awareness and De-Stigmatization of Urinary Health Expands Addressable Market Opportunity
    • Shift Toward Point-of-Care and Home Testing Solutions Drives Adoption in Non-Clinical Settings
    • Technological Advancements in Molecular Diagnostics Propel Innovation in UTI Test Accuracy and Speed
    • Expansion of Telehealth Platforms Throws the Spotlight on Remote UTI Diagnosis and Testing Integration
    • Widespread Antibiotic Resistance Crisis Accelerates Demand for Pathogen-Specific UTI Testing
    • Consumer Preference for Privacy and Convenience Generates Growth in Over-the-Counter UTI Test Kits
    • Incorporation of AI and Digital Health Tools Enhances Decision Support and Test Interpretation Accuracy
    • Rising Healthcare-Associated UTI Incidence in Hospitals and Long-Term Care Sustains Demand for Surveillance Testing
    • Availability of UTI Testing Through Online Pharmacies and E-Commerce Channels Expands Patient Access
    • Integration of UTI Testing into Preventive and Women's Health Programs Creates New Growth Avenues
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Urinary Tract Infection Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Urinary Tract Infection Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Urethritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Urethritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Urethritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cystitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cystitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cystitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pyelonephritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pyelonephritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Pyelonephritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Urgent Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Urgent Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Urgent Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for General Practitioners by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for General Practitioners by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for General Practitioners by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Urologists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Urologists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Urologists by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Urogynecologists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Urogynecologists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Urogynecologists by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospital Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospital Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Hospital Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospital Emergency Departments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospital Emergency Departments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Hospital Emergency Departments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • JAPAN
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • CHINA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • EUROPE
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Urinary Tract Infection Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • FRANCE
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • GERMANY
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Spain 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Spain 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Russia 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Russia 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Urinary Tract Infection Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Australia 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Australia 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • INDIA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 128: India Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: India 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 131: India Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: India 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: South Korea 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: South Korea 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Urinary Tract Infection Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Latin America 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Argentina 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Argentina 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Brazil 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Brazil 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Mexico 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Mexico 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Urinary Tract Infection Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Middle East 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Iran 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Iran 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Israel 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Israel 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: UAE 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: UAE 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • AFRICA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Africa 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Africa 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030

IV. COMPETITION